|
|
 |
|
Viewing report
|
|
|
|
Psoriasis Drugs - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 568
This report analyzes the worldwide markets for Psoriasis Drugs in US$ Million by the following Drug Administration Routes - Systemic Drugs, and Topical Drugs. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 69 companies including many key and niche players such as Abbott Laboratories, Amgen Inc., Almirall SA, Astellas Pharma US, Inc., Biogen Idec, Inc., Eisai Co. Ltd., Galderma Laboratories, Isis Pharmaceuticals, Inc., Johnson & Johnson Company, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Stiefel Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Vertex Pharmaceuticals, Inc., and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Guide to U.S. Specialty Pharmaceutical Market: Companies, Products and Market Data
The U.S. Psoriasis Market Capsule
Psoriasis Global Clinical Trials Review, Q1, 2011
Chronic Plaque Psoriasis Global Clinical Trials Review, Q2, 2011
Transdermal Drug Delivery - Technologies, Markets, and Companies
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study
U.S. Market for Psoriasis Cream and Medication 2009
Intranasal Drug Delivery - Global Strategic Business Report
|
|
|
|
